These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21575583)

  • 21. Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.
    Lu Z; Hunter T
    Cell Cycle; 2010 Jun; 9(12):2342-52. PubMed ID: 20519948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I; Polyak K; Iavarone A; Massagué J
    Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New functional activities for the p21 family of CDK inhibitors.
    LaBaer J; Garrett MD; Stevenson LF; Slingerland JM; Sandhu C; Chou HS; Fattaey A; Harlow E
    Genes Dev; 1997 Apr; 11(7):847-62. PubMed ID: 9106657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural prediction of the interaction of the tumor suppressor p27
    Li J; Vervoorts J; Carloni P; Rossetti G; Lüscher B
    BMC Bioinformatics; 2017 Jan; 18(1):15. PubMed ID: 28056778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of cyclin dependent kinase inhibitors of KIP family in gastric cancer].
    Lee SJ; Joo YE; Kim HS; Choi SK; Rew JS; Park CS; Kim SJ
    Korean J Gastroenterol; 2005 Aug; 46(2):84-93. PubMed ID: 16118517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cdk2-dependent Inhibition of p21 stability via a C-terminal cyclin-binding motif.
    Zhu H; Nie L; Maki CG
    J Biol Chem; 2005 Aug; 280(32):29282-8. PubMed ID: 15964852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-Time Analysis of Folding upon Binding of a Disordered Protein by Using Dissolution DNP NMR Spectroscopy.
    Ragavan M; Iconaru LI; Park CG; Kriwacki RW; Hilty C
    Angew Chem Int Ed Engl; 2017 Jun; 56(25):7070-7073. PubMed ID: 28508552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.
    Croucher DR; Rickwood D; Tactacan CM; Musgrove EA; Daly RJ
    Mol Cell Biol; 2010 Nov; 30(21):5057-70. PubMed ID: 20805359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The peptidyl-prolyl isomerase PIN1 relieves cyclin-dependent kinase 2 (CDK2) inhibition by the CDK inhibitor p27.
    Cheng CW; Leong KW; Ng YM; Kwong YL; Tse E
    J Biol Chem; 2017 Dec; 292(52):21431-21441. PubMed ID: 29118189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding.
    Lacy ER; Filippov I; Lewis WS; Otieno S; Xiao L; Weiss S; Hengst L; Kriwacki RW
    Nat Struct Mol Biol; 2004 Apr; 11(4):358-64. PubMed ID: 15024385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the Effect of Zebularine in Comparison to and in Combination with Trichostatin A on p21Cip1/Waf1/ Sdi1, p27Kip1, p57Kip2, DNA Methyltransferases and Histone Deacetylases in Colon Cancer LS 180 Cell Line.
    Sanaei M; Kavoosi F
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1819-1828. PubMed ID: 32592383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
    Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE
    Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of p27 Unfolding for CDK2 Reactivation.
    Rath SL; Senapati S
    Sci Rep; 2016 May; 6():26450. PubMed ID: 27211815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and functional analysis of cyclin D1 reveals p27 and substrate inhibitor binding requirements.
    Liu S; Bolger JK; Kirkland LO; Premnath PN; McInnes C
    ACS Chem Biol; 2010 Dec; 5(12):1169-82. PubMed ID: 20843055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
    Chen WJ; Chang CY; Lin JK
    Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
    Schulze-Gahmen U; Jung JU; Kim SH
    Structure; 1999 Mar; 7(3):245-54. PubMed ID: 10368294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of cyclin D1 and D2 in protecting against cardiomyocyte proliferation.
    Tamamori-Adachi M; Goto I; Yamada K; Kitajima S
    Cell Cycle; 2008 Dec; 7(23):3768-774. PubMed ID: 19029821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.
    Blain SW; Montalvo E; Massagué J
    J Biol Chem; 1997 Oct; 272(41):25863-72. PubMed ID: 9325318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
    Upton JW; van Dyk LF; Speck SH
    Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.